Iron release in erythrocytes from patients with β-thalassemia

Our previous studies have shown that iron is released in a free (desferrioxamine-chelatable) form when erythrocytes undergo oxidative stress (incubation with oxidizing agents or aerobic incubation in buffer for 24-60 h (a model of rapid in vitro ageing)). The release is accompanied by oxidative alte...

Full description

Saved in:
Bibliographic Details
Published inFree radical research Vol. 30; no. 5; pp. 407 - 413
Main Authors Ciccoli, Lucia, Signorini, Cinzia, Scarano, Clelia, Rossi, Viviana, Bambagioni, Sabrina, Ferrali, Marco, Comporti, Mario
Format Journal Article
LanguageEnglish
Published England Informa UK Ltd 01.01.1999
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Our previous studies have shown that iron is released in a free (desferrioxamine-chelatable) form when erythrocytes undergo oxidative stress (incubation with oxidizing agents or aerobic incubation in buffer for 24-60 h (a model of rapid in vitro ageing)). The release is accompanied by oxidative alterations of membrane proteins as well as by the appearance of senescent antigen, a signal for termination of old erythrocytes. In hemolytic anemias by hereditary hemoglobin alterations an accelerated removal of erythrocytes occurs. An increased susceptibility to oxidative damage has been reported in β-thalassemic erythrocytes. Therefore we have investigated whether an increased iron level and an increased susceptibility to iron release could be observed in the erythrocytes from patients with β-thalassemia. Erythrocytes from subjects with thalassemia intermedia showed an extremely higher content (0 time value) of free iron and methemoglobin as compared to controls. An increase, although non-statistically-significant, was seen in erythrocytes from subjects with thalassemia major. Upon aerobic incubation for 24 h the release of iron in β-thalassemic erythrocytes was by far greater than in controls, with the exception of thalassemia minor. When the individual values for free iron content (0 time) seen in thalassemia major and intermedia were plotted against the corresponding values for HbF, a positive correlation (P < 0.001) was observed. Also, a positive correlation (P < 0.01) was seen between the values for free iron release (24 h incubation) and the values for HbF. These results suggest that the presence of HbF is a condition favourable to iron release. Since in β-thalassemia the persistance of HbF is related to the lack or deficiency of β chains and therefore to the excess of α chains, the observed correlation between fre iron and HbF, is consistent with the hypothesis by others that excess of α chains represents a prooxidant factor.
AbstractList Our previous studies have shown that iron is released in a free (desferrioxamine-chelatable) form when erythrocytes undergo oxidative stress (incubation with oxidizing agents or aerobic incubation in buffer for 24-60 h (a model of rapid in vitro ageing)). The release is accompanied by oxidative alterations of membrane proteins as well as by the appearance of senescent antigen, a signal for termination of old erythrocytes. In hemolytic anemias by hereditary hemoglobin alterations an accelerated removal of erythrocytes occurs. An increased susceptibility to oxidative damage has been reported in beta-thalassemic erythrocytes. Therefore we have investigated whether an increased iron level and an increased susceptibility to iron release could be observed in the erythrocytes from patients with beta-thalassemia. Erythrocytes from subjects with thalassemia intermedia showed an extremely higher content (0 time value) of free iron and methemoglobin as compared to controls. An increase, although non-statistically-significant, was seen in erythrocytes from subjects with thalassemia major. Upon aerobic incubation for 24 h the release of iron in beta-thalassemic erythrocytes was by far greater than in controls, with the exception of thalassemia minor. When the individual values for free iron content (0 time) seen in thalassemia major and intermedia were plotted against the corresponding values for HbF, a positive correlation (P < 0.001) was observed. Also, a positive correlation (P < 0.01) was seen between the values for free iron release (24 h incubation) and the values for HbF. These results suggest that the presence of HbF is a condition favourable to iron release. Since in beta-thalassemia the persistance of HbF is related to the lack or deficiency of beta chains and therefore to the excess of alpha chains, the observed correlation between free iron and HbF, is consistent with the hypothesis by others that excess of alpha chains represents a prooxidant factor.
Our previous studies have shown that iron is released in a free (desferrioxamine-chelatable) form when erythrocytes undergo oxidative stress (incubation with oxidizing agents or aerobic incubation in buffer for 24-60 h (a model of rapid in vitro ageing)). The release is accompanied by oxidative alterations of membrane proteins as well as by the appearance of senescent antigen, a signal for termination of old erythrocytes. In hemolytic anemias by hereditary hemoglobin alterations an accelerated removal of erythrocytes occurs. An increased susceptibility to oxidative damage has been reported in β-thalassemic erythrocytes. Therefore we have investigated whether an increased iron level and an increased susceptibility to iron release could be observed in the erythrocytes from patients with β-thalassemia. Erythrocytes from subjects with thalassemia intermedia showed an extremely higher content (0 time value) of free iron and methemoglobin as compared to controls. An increase, although non-statistically-significant, was seen in erythrocytes from subjects with thalassemia major. Upon aerobic incubation for 24 h the release of iron in β-thalassemic erythrocytes was by far greater than in controls, with the exception of thalassemia minor. When the individual values for free iron content (0 time) seen in thalassemia major and intermedia were plotted against the corresponding values for HbF, a positive correlation (P < 0.001) was observed. Also, a positive correlation (P < 0.01) was seen between the values for free iron release (24 h incubation) and the values for HbF. These results suggest that the presence of HbF is a condition favourable to iron release. Since in β-thalassemia the persistance of HbF is related to the lack or deficiency of β chains and therefore to the excess of α chains, the observed correlation between fre iron and HbF, is consistent with the hypothesis by others that excess of α chains represents a prooxidant factor.
Our previous studies have shown that iron is released in a free (desferrioxamine-chelatable) form when erythrocytes undergo oxidative stress (incubation with oxidizing agents or aerobic incubation in buffer for 24-60 h (a model of rapid in vitro ageing)). The release is accompanied by oxidative alterations of membrane proteins as well as by the appearance of senescent antigen, a signal for termination of old erythrocytes. In hemolytic anemias by hereditary hemoglobin alterations an accelerated removal of erythrocytes occurs. An increased susceptibility to oxidative damage has been reported in beta-thalassemic erythrocytes. Therefore we have investigated whether an increased iron level and an increased susceptibility to iron release could be observed in the erythrocytes from patients with beta-thalassemia. Erythrocytes from subjects with thalassemia intermedia showed an extremely higher content (0 time value) of free iron and methemoglobin as compared to controls. An increase, although non-statistically-significant, was seen in erythrocytes from subjects with thalassemia major. Upon aerobic incubation for 24 h the release of iron in beta-thalassemic erythrocytes was by far greater than in controls, with the exception of thalassemia minor. When the individual values for free iron content (0 time) seen in thalassemia major and intermedia were plotted against the corresponding values for HbF, a positive correlation (P &lt; 0.001) was observed. Also, a positive correlation (P &lt; 0.01) was seen between the values for free iron release (24 h incubation) and the values for HbF. These results suggest that the presence of HbF is a condition favourable to iron release. Since in beta-thalassemia the persistance of HbF is related to the lack or deficiency of beta chains and therefore to the excess of alpha chains, the observed correlation between free iron and HbF, is consistent with the hypothesis by others that excess of alpha chains represents a prooxidant factor.
Author Scarano, Clelia
Comporti, Mario
Ferrali, Marco
Ciccoli, Lucia
Bambagioni, Sabrina
Signorini, Cinzia
Rossi, Viviana
Author_xml – sequence: 1
  givenname: Lucia
  surname: Ciccoli
  fullname: Ciccoli, Lucia
  organization: 1Istituto di Patologia Generale, Università di Siena, Via Aldo Moro, I-5300, Siena, Italy
– sequence: 2
  givenname: Cinzia
  surname: Signorini
  fullname: Signorini, Cinzia
  organization: 1Istituto di Patologia Generale, Università di Siena, Via Aldo Moro, I-5300, Siena, Italy
– sequence: 3
  givenname: Clelia
  surname: Scarano
  fullname: Scarano, Clelia
  organization: 1Istituto di Patologia Generale, Università di Siena, Via Aldo Moro, I-5300, Siena, Italy
– sequence: 4
  givenname: Viviana
  surname: Rossi
  fullname: Rossi, Viviana
  organization: 1Istituto di Patologia Generale, Università di Siena, Via Aldo Moro, I-5300, Siena, Italy
– sequence: 5
  givenname: Sabrina
  surname: Bambagioni
  fullname: Bambagioni, Sabrina
  organization: 1Istituto di Patologia Generale, Università di Siena, Via Aldo Moro, I-5300, Siena, Italy
– sequence: 6
  givenname: Marco
  surname: Ferrali
  fullname: Ferrali, Marco
  organization: 1Istituto di Patologia Generale, Università di Siena, Via Aldo Moro, I-5300, Siena, Italy
– sequence: 7
  givenname: Mario
  surname: Comporti
  fullname: Comporti, Mario
  organization: 1Istituto di Patologia Generale, Università di Siena, Via Aldo Moro, I-5300, Siena, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/10342333$$D View this record in MEDLINE/PubMed
BookMark eNp9kM1q3DAUhUVJaP76AN0Er7pzc_XjsURCIYS0DQS6adbiWr7CDrY0lTSEea0-SJ4pHiaLlEJW9y6-czh8J-wgxECMfebwlYOGCw4tb9qVMQASQCn-gR1zEKYWqoWD3d_yegHEETvJ-RGAS9W0H9kRB6mElPKYfbtLMVSJJsJM1RgqStsypOi2hXLlU5yrNZaRQsnV01iG6vlvXQacMGeaRzxjhx6nTJ9e7yl7-H77--Znff_rx93N9X3tFIhSa99r7wzqzgmzUrJxqvNcQddpoaVuZQdCSanRKQLFe4W9apSXaLhpzDL0lH3Z965T_LOhXOw8ZkfThIHiJtuVaVujxQ7ke9ClmHMib9dpnDFtLQe7k2b_k7Zkzl_LN91M_ZvE3tICXO2BMfiYZnyKaeptwe0Uk08Y3JitfK__8p_4QDiVwWEi-xg3KSzi3ln3Avjyjc0
CitedBy_id crossref_primary_10_1016_j_arr_2023_101931
crossref_primary_10_1016_S0891_5849_02_00759_1
crossref_primary_10_1080_10715760802317655
crossref_primary_10_1590_S1415_47572011005000026
crossref_primary_10_1111_j_1651_2227_2002_tb02918_x
crossref_primary_10_1016_j_freeradbiomed_2019_05_014
crossref_primary_10_1016_j_bbagen_2004_04_003
crossref_primary_10_1016_j_freeradbiomed_2005_11_021
crossref_primary_10_1203_01_PDR_0000180545_24457_AC
crossref_primary_10_1371_journal_pone_0146448
Cites_doi 10.1021/bi00322a006
10.1182/blood.V72.4.1278.1278
10.1016/S0021-9258(18)93628-8
10.1182/blood.V47.3.495.495
10.1182/blood.V82.10.3204.3204
10.1182/blood.V70.1.158.158
10.1016/0005-2736(94)90298-4
10.1182/blood.V87.9.3948.bloodjournal8793948
10.1111/j.1432-1033.1975.tb04046.x
10.1016/0047-6374(82)90049-5
10.1016/S0021-9258(18)97685-4
10.1172/JCI113898
10.1182/blood.V63.2.362.362
10.1111/j.1365-2141.1973.tb01721.x
10.1042/bj2850295
10.1172/JCI110870
10.1016/S0021-9258(17)42604-4
10.1172/JCI116380
10.1016/0891-5849(94)00160-L
10.1111/j.1600-0609.1981.tb01370.x
10.1073/pnas.83.16.6137
10.1111/j.1365-2141.1969.tb00375.x
10.1016/S0021-9258(18)73873-8
10.1016/S0021-9258(18)98470-X
10.1016/0014-5793(78)80470-0
10.1182/blood.V84.1.315.315
10.1016/S0021-9258(18)47778-2
10.1248/bpb.18.659
10.1016/0014-5793(95)00235-2
10.1182/blood.V79.11.3007.3007
10.1056/NEJM197909063011004
10.1182/blood.V79.6.1586.1586
10.1016/0006-2952(90)90444-P
10.1016/0006-2952(89)90417-6
10.1016/0005-2736(87)90325-7
ContentType Journal Article
Copyright 1999 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1999
Copyright_xml – notice: 1999 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1999
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1080/10715769900300441
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1029-2470
EndPage 413
ExternalDocumentID 10_1080_10715769900300441
10342333
11227824
Genre Original Article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.HR
00X
03L
0BK
0R~
29H
30N
36B
4.4
53G
5GY
5VS
A8Z
AAAVI
AAGME
AAJMT
AALDU
AALIY
AAMIU
AAOAP
AAPUL
AAPXX
AAQRR
ABCCY
ABDBF
ABFIM
ABFMO
ABJNI
ABJVF
ABJYH
ABLIJ
ABLKL
ABQHQ
ABXUL
ABXYU
ACBBU
ACDHJ
ACFUF
ACGEJ
ACGFS
ACQMU
ACTIO
ADCVX
ADFCX
ADGTB
ADGTR
ADOPC
ADRBQ
ADXPE
AEGYZ
AEISY
AENEX
AEOZL
AEPSL
AEYOC
AEYQI
AFDYB
AFFNX
AFKVX
AFOSN
AFWLO
AGDLA
AHDLD
AIJEM
AIRXU
AJWEG
AKBVH
AKOOK
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
APNXG
AQRUH
AURDB
AWQZV
AWYRJ
BABNJ
BFWEY
BLEHA
CAG
CCCUG
COF
CS3
CWRZV
DGEBU
DKSSO
DU5
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
EST
ESTFP
ESX
F5P
HGUVV
HZ~
JEPSP
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M44
M4Z
MM.
O9-
OWHGL
P2P
PCLFJ
RNANH
RNS
ROSJB
RTWRZ
SV3
TFDNU
TFL
TFT
TFW
TQWBC
TTHFI
TUS
V1S
Z0Y
ZGOLN
ZXP
~1N
ABBKH
ABPTK
H13
J.N
ABPAQ
ABTAA
AHDZW
CGR
CUY
CVF
ECM
EIF
NPM
NUSFT
TBQAZ
TDBHL
TUROJ
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c402t-8fd8fc9a8bc296435c4bf140bb8283873b024338ac4e041d4ad454f3a91959333
ISSN 1071-5762
IngestDate Fri Oct 25 05:47:37 EDT 2024
Fri Aug 23 03:08:36 EDT 2024
Tue Oct 15 23:20:52 EDT 2024
Tue Jun 13 19:54:08 EDT 2023
Wed Mar 06 06:19:10 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c402t-8fd8fc9a8bc296435c4bf140bb8283873b024338ac4e041d4ad454f3a91959333
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 10342333
PQID 69779823
PQPubID 23479
PageCount 7
ParticipantIDs crossref_primary_10_1080_10715769900300441
informahealthcare_journals_10_1080_10715769900300441
informaworld_taylorfrancis_310_1080_10715769900300441
proquest_miscellaneous_69779823
pubmed_primary_10342333
PublicationCentury 1900
PublicationDate 1999-01-01
PublicationDateYYYYMMDD 1999-01-01
PublicationDate_xml – month: 01
  year: 1999
  text: 1999-01-01
  day: 01
PublicationDecade 1990
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Free radical research
PublicationTitleAlternate Free Radic Res
PublicationYear 1999
Publisher Informa UK Ltd
Taylor & Francis
Publisher_xml – name: Informa UK Ltd
– name: Taylor & Francis
References Bunn H.F. (CIT0017) 1967; 243
Beutler E. (CIT0034) 1963; 61
Johnson G.J. (CIT0013) 1979; 301
Evelyn K.A. (CIT0033) 1938; 126
Schwartz R.S. (CIT0010) 1987; 262
Beppu M. (CIT0007) 1987; 897
Shalev O. (CIT0041) 1996; 87
Kahane I (CIT0011) 1978; 85
Ando K. (CIT0003) 1995; 18
Brunori M. (CIT0018) 1975; 53
Lubin B.H. (CIT0036) 1993
Caseyand J.R. (CIT0006) 1991; 266
Beppu M. (CIT0008) 1994; 1196
Shinar E. (CIT0037) 1987; 70
Sadrzadeh S.M.H. (CIT0019) 1984; 259
Schlüter K. (CIT0030) 1986; 83
Waugh S.M. (CIT0002) 1985; 24
Gerli G.C. (CIT0024) 1980; 25
Hochstein P. (CIT0004) 1981; 40
Schrier S.L. (CIT0032) 1938; 79
Ferrali M. (CIT0028) 1990; 40
Flynn T.P. (CIT0012) 1983; 71
Beppu M. (CIT0001) 1996; 42
Yuan J. (CIT0031) 1992; 79
Bucci E. (CIT0035) 1965; 240
Ferrali M. (CIT0027) 1992; 285
Signorini C. (CIT0029) 1995; 362
Scott M.D. (CIT0016) 1993; 91
Joshi W. (CIT0021) 1983; 102
Grinberg L.N. (CIT0025) 1995; 18
Kuross S.A. (CIT0020) 1988; 72
Ferrali M. (CIT0026) 1989; 38
Shinar E. (CIT0038) 1989; 83
Repka T. (CIT0040) 1993; 82
Olivieri O. (CIT0039) 1994; 84
Bartosz G. (CIT0005) 1982; 19
Scott M.D. (CIT0022) 1991; 78
Vigi V. (CIT0014) 1969; 16
Wickramasinghe S.N. (CIT0015) 1973; 25
Rachmilewitz E.A. (CIT0023) 1976; 47
Jain S.K. (CIT0009) 1984; 63
References_xml – volume: 24
  start-page: 34
  year: 1985
  ident: CIT0002
  publication-title: Biochemistry
  doi: 10.1021/bi00322a006
  contributor:
    fullname: Waugh S.M.
– volume: 72
  start-page: 1278
  year: 1988
  ident: CIT0020
  publication-title: Blood
  doi: 10.1182/blood.V72.4.1278.1278
  contributor:
    fullname: Kuross S.A.
– volume: 243
  start-page: 465
  year: 1967
  ident: CIT0017
  publication-title: Journal of Biological Chemistry
  doi: 10.1016/S0021-9258(18)93628-8
  contributor:
    fullname: Bunn H.F.
– volume: 78
  start-page: 771
  issue: 1
  year: 1991
  ident: CIT0022
  publication-title: Blood
  contributor:
    fullname: Scott M.D.
– volume: 47
  start-page: 495
  year: 1976
  ident: CIT0023
  publication-title: Blood
  doi: 10.1182/blood.V47.3.495.495
  contributor:
    fullname: Rachmilewitz E.A.
– volume: 82
  start-page: 3204
  year: 1993
  ident: CIT0040
  publication-title: Blood
  doi: 10.1182/blood.V82.10.3204.3204
  contributor:
    fullname: Repka T.
– volume: 42
  start-page: 1007
  year: 1996
  ident: CIT0001
  publication-title: Cellular and Molecular Biology
  contributor:
    fullname: Beppu M.
– volume: 70
  start-page: 158
  year: 1987
  ident: CIT0037
  publication-title: Blood
  doi: 10.1182/blood.V70.1.158.158
  contributor:
    fullname: Shinar E.
– volume: 1196
  start-page: 81
  year: 1994
  ident: CIT0008
  publication-title: Biochimica and Biophysical Acta
  doi: 10.1016/0005-2736(94)90298-4
  contributor:
    fullname: Beppu M.
– volume: 87
  start-page: 3948
  year: 1996
  ident: CIT0041
  publication-title: Blood
  doi: 10.1182/blood.V87.9.3948.bloodjournal8793948
  contributor:
    fullname: Shalev O.
– volume: 53
  start-page: 99
  year: 1975
  ident: CIT0018
  publication-title: European Journal of Biochemistry
  doi: 10.1111/j.1432-1033.1975.tb04046.x
  contributor:
    fullname: Brunori M.
– volume: 19
  start-page: 45
  year: 1982
  ident: CIT0005
  publication-title: Mechanisms Ageing Development
  doi: 10.1016/0047-6374(82)90049-5
  contributor:
    fullname: Bartosz G.
– volume: 240
  start-page: 551
  year: 1965
  ident: CIT0035
  publication-title: Journal of Biological Chemistry
  doi: 10.1016/S0021-9258(18)97685-4
  contributor:
    fullname: Bucci E.
– volume: 83
  start-page: 404
  year: 1989
  ident: CIT0038
  publication-title: Journal of Clinical Investigation
  doi: 10.1172/JCI113898
  contributor:
    fullname: Shinar E.
– volume: 63
  start-page: 362
  year: 1984
  ident: CIT0009
  publication-title: Blood
  doi: 10.1182/blood.V63.2.362.362
  contributor:
    fullname: Jain S.K.
– volume: 25
  start-page: 123
  year: 1973
  ident: CIT0015
  publication-title: British Journal of Haematology
  doi: 10.1111/j.1365-2141.1973.tb01721.x
  contributor:
    fullname: Wickramasinghe S.N.
– volume: 285
  start-page: 295
  year: 1992
  ident: CIT0027
  publication-title: Biochemical Journal
  doi: 10.1042/bj2850295
  contributor:
    fullname: Ferrali M.
– volume: 71
  start-page: 1215
  year: 1983
  ident: CIT0012
  publication-title: Journal of Clinical Investigation
  doi: 10.1172/JCI110870
  contributor:
    fullname: Flynn T.P.
– volume: 259
  start-page: 14354
  year: 1984
  ident: CIT0019
  publication-title: Journal of Biological Chemistry
  doi: 10.1016/S0021-9258(17)42604-4
  contributor:
    fullname: Sadrzadeh S.M.H.
– volume: 91
  start-page: 1706
  year: 1993
  ident: CIT0016
  publication-title: Journal of Clinical Investigation
  doi: 10.1172/JCI116380
  contributor:
    fullname: Scott M.D.
– volume: 102
  start-page: 46
  year: 1983
  ident: CIT0021
  publication-title: Journal of Laboratory and Clinical Medicine
  contributor:
    fullname: Joshi W.
– volume: 18
  start-page: 611
  year: 1995
  ident: CIT0025
  publication-title: Free Radical Biology and Medicine
  doi: 10.1016/0891-5849(94)00160-L
  contributor:
    fullname: Grinberg L.N.
– volume: 25
  start-page: 87
  year: 1980
  ident: CIT0024
  publication-title: Scandinavian Journal of Haematology
  doi: 10.1111/j.1600-0609.1981.tb01370.x
  contributor:
    fullname: Gerli G.C.
– volume: 83
  start-page: 6137
  year: 1986
  ident: CIT0030
  publication-title: Proceedings of the National Academy of Sciences of the USA
  doi: 10.1073/pnas.83.16.6137
  contributor:
    fullname: Schlüter K.
– volume: 16
  start-page: 25
  year: 1969
  ident: CIT0014
  publication-title: British Journal of Haematology
  doi: 10.1111/j.1365-2141.1969.tb00375.x
  contributor:
    fullname: Vigi V.
– volume: 126
  start-page: 655
  year: 1938
  ident: CIT0033
  publication-title: Journal of Biological Chemistry
  doi: 10.1016/S0021-9258(18)73873-8
  contributor:
    fullname: Evelyn K.A.
– volume: 266
  start-page: 15726
  year: 1991
  ident: CIT0006
  publication-title: Journal of Biological Chemistry
  doi: 10.1016/S0021-9258(18)98470-X
  contributor:
    fullname: Caseyand J.R.
– volume: 85
  start-page: 267
  year: 1978
  ident: CIT0011
  publication-title: FEBS Letters
  doi: 10.1016/0014-5793(78)80470-0
  contributor:
    fullname: Kahane I
– volume: 84
  start-page: 315
  year: 1994
  ident: CIT0039
  publication-title: Blood
  doi: 10.1182/blood.V84.1.315.315
  contributor:
    fullname: Olivieri O.
– volume: 262
  start-page: 15666
  year: 1987
  ident: CIT0010
  publication-title: Journal of Biological Chemistry
  doi: 10.1016/S0021-9258(18)47778-2
  contributor:
    fullname: Schwartz R.S.
– volume: 18
  start-page: 659
  year: 1995
  ident: CIT0003
  publication-title: Biology and Pharmacology Bulletin
  doi: 10.1248/bpb.18.659
  contributor:
    fullname: Ando K.
– volume: 362
  start-page: 165
  year: 1995
  ident: CIT0029
  publication-title: FEBS Letters
  doi: 10.1016/0014-5793(95)00235-2
  contributor:
    fullname: Signorini C.
– start-page: 79
  volume-title: Neonatal Immunology and Haematology II
  year: 1993
  ident: CIT0036
  contributor:
    fullname: Lubin B.H.
– volume: 79
  start-page: 3007
  year: 1992
  ident: CIT0031
  publication-title: Blood
  doi: 10.1182/blood.V79.11.3007.3007
  contributor:
    fullname: Yuan J.
– volume: 301
  start-page: 522
  year: 1979
  ident: CIT0013
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJM197909063011004
  contributor:
    fullname: Johnson G.J.
– volume: 61
  start-page: 882
  year: 1963
  ident: CIT0034
  publication-title: Journal of Laboratory and Clinical Medicine
  contributor:
    fullname: Beutler E.
– volume: 79
  start-page: 1586
  year: 1938
  ident: CIT0032
  publication-title: Blood
  doi: 10.1182/blood.V79.6.1586.1586
  contributor:
    fullname: Schrier S.L.
– volume: 40
  start-page: 1485
  year: 1990
  ident: CIT0028
  publication-title: Biochemical Pharmacology
  doi: 10.1016/0006-2952(90)90444-P
  contributor:
    fullname: Ferrali M.
– volume: 38
  start-page: 1819
  year: 1989
  ident: CIT0026
  publication-title: Biochemical Pharmacology
  doi: 10.1016/0006-2952(89)90417-6
  contributor:
    fullname: Ferrali M.
– volume: 40
  start-page: 183
  year: 1981
  ident: CIT0004
  publication-title: Federation Proceedings
  contributor:
    fullname: Hochstein P.
– volume: 897
  start-page: 169
  year: 1987
  ident: CIT0007
  publication-title: Biochimica and Biophysical Acta
  doi: 10.1016/0005-2736(87)90325-7
  contributor:
    fullname: Beppu M.
SSID ssj0013457
Score 1.6507049
Snippet Our previous studies have shown that iron is released in a free (desferrioxamine-chelatable) form when erythrocytes undergo oxidative stress (incubation with...
SourceID proquest
crossref
pubmed
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Publisher
StartPage 407
SubjectTerms Adult
beta-Thalassemia - metabolism
Erythrocytes
Erythrocytes - drug effects
Erythrocytes - metabolism
Fetal Hemoglobin - metabolism
foetal hemoglobin (HbF)
Glutathione - metabolism
Humans
Iron - metabolism
iron release
Monomethylhydrazine - pharmacology
oxidative stress
Phenylhydrazines - pharmacology
Reference Values
β-thalassemia
Title Iron release in erythrocytes from patients with β-thalassemia
URI https://www.tandfonline.com/doi/abs/10.1080/10715769900300441
https://www.ncbi.nlm.nih.gov/pubmed/10342333
https://search.proquest.com/docview/69779823
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FVoJeUCmv8NwDvVAZEu_aWZ9QMa0CUjlACxUXa1-mlloHOQ6o_Vn8EH4Tsw8_aGhFuVjJbryOPePZ2fl2vkHoGTQK8FJVMAH3N6BK5QEXGhw5JmMlJkIklqx67308PaDvDqPDweBHP7ukFi_k2V_zSv5HqtAGcjVZsleQbDsoNMBnkC8cQcJw_CcZv61mNhvFQCyW-6M6NWUP5KkJptrEEU-b6nPYNtOdzdfhVlAfmezJuT4peN853a203qq4Q248C1AbLU4LCTrjcqkXsmit-cfia2k28dmetCjPel2Sw0zoYrHH-rjr-AAzs_39p-I7qCfvQg-OrqANPThrCf5JEDXmVPu20EA2rhpIY2I99FL0QWxrL6kreeunXurSUpesutsGaa4GF0tM7NXg0ONuCmtg-3MzW7vfcOyJUJeGuIZWQ7BQYBpXt6dvvnzuAChqSWLbO2wAcTZ6uTTIHy7Nuie8PWq3750jwb14KWNdmv11dNOvRfC2U6xbaKDLDXQjbUoAbqDre37nxW30yuga9rqGixL3dQ0bXcONrmGja_jXT9zXszvoYHdnP50GvvhGIOkorAOWK5bLhDMhDTJPIklFDqtxIWCNTtiECMNlSRiXVI_oWFGuaERzwhNDV0QIuYtWylmp7yNM81gqoogUPKeMMp7EKg5DSUJmvk2G6Hnz_LJvjmMlu1BiQ0SXnnDm38n5ZadFfSFktY2H5a54TUYuOe9pI60MHr5B03ipZ4t5FsPKKWEhGaJ7Toi9_25oNQl5cJX7eojWulfsEVqpq4V-DP5uLZ543fwNPIehoA
link.rule.ids 315,783,787,27936,27937,60214,61003,61689,61870
linkProvider Library Specific Holdings
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LTtwwFL1CIEE3QGkLA7R40VWljJjYkzgbJIRAQ8vMipHYWX7EoqqUqSaZBXwWH8I3cW_i8GYWs4oS2U78is99nQvwEx8aRKkuShH-RsI5H2mTI5CTNnEmNSaryaqHo2QwFr-v-ldB4VYGt0qSoX1DFFH_q2lzkzK6dYnDa9pDnJyRFo4skij9rCRE_kUhHIejJyuCqJk-qXiE5ePWqvleEy_Opc3AWnr96IP1isn0Yzxan0tnG6DaHjXuKP-6s8p07e0rssfFu7wJ6wGysuNmjX2GpbzYgrWTNlPcFqwOg4H-CxydTycFo0QseDqyvwXLpzeUicHeIKRlFMvCApNryUgFzO7vouqaYjlLbE5_hfHZ6eXJIAopGiKLgmcVSe-kt5mWxpL9lvetMB5lNmNQkuMy5YYYD7nUVuSHoueEdqIvPNcZkdpwzr_BcjEp8h1gwifWccet0V5IIXWWuCSOLY8l3aUd-NVOkPrfMHGoXiA4fTM6HRBvplCF3VnOq9Z_PsuqqrUmvklxovicegftclA49mRz0UU-mZUqQXydyZh3YLtZJc--ncgXOd9d8J0HsDa4HF6oi_PRnz341NBJkGpoH5ar6Sz_jmCpMj_qHfEAoQ0G3g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELUQSMAFyl62-sAJKaiN3cS5IKFCxVpxAIlb5CVWEVJaNemhfBYfwjcxkzhQ1gOnKJHtOPY4frP4DSEH8FABSjVeCPDX48ZYT6oEgJzQgVGhUlFBVn3TC87v-eVD-8HF5mQurBJ1aFsSRRT_alzcQ2OriDi4hi2AyREa4dAhCcrPHKCAJoo5a_Y-nAi8IPrE4h6U9yun5k9NfNqWao60tP8egvWFyPR3OFpsS93lMvdqVrAZYjTK09E4V0f6-QvX47-_uEaWHGClJ6WErZCZJF0lC50qT9wqmb9x7vk1cnwxGqQU07DA3kgfU5qMJpiHQU8A0FI8yUIdj2tG0QBMX1-8vI8nOTNoTq6T--7ZXefccwkaPA1qZ-4Ja4TVkRRKo_eWtTVXFjQ2pUCPYyJkCvkOmZCaJ03eMlwa3uaWyQgpbRhjG2Q2HaTJFqHcBtoww7SSlgsuZBSYwPc18wXehXVyWM1PPCx5OOKWozf9Njp1wr_NYOzWZvZXtfb0JMd5YTOxZYKTmP1Rr1FJQwxjjx4XmSaDcRYHgK4j4bM62SyFZKrvSL3I2PY_39kg87en3fj6one1QxZLLgm0C-2S2Xw0TvYAKeVqv1gPb3SyBYs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Iron+release+in+erythrocytes+from+patients+with+%CE%B2+-thalassemia&rft.jtitle=Free+radical+research&rft.au=Ciccoli%2C+Lucia&rft.au=Signorini%2C+Cinzia&rft.au=Scarano%2C+Clelia&rft.au=Rossi%2C+Viviana&rft.date=1999-01-01&rft.issn=1071-5762&rft.eissn=1029-2470&rft.volume=30&rft.issue=5&rft.spage=407&rft.epage=413&rft_id=info:doi/10.1080%2F10715769900300441&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_10715769900300441
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1071-5762&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1071-5762&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1071-5762&client=summon